This site is intended for healthcare professionals
Clinical trials
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • ROCS (Radiotherapy After Oesophageal Cancer Stenti...
Clinical trial

ROCS (Radiotherapy After Oesophageal Cancer Stenting) Study

Read time: 1 mins
Last updated:31st Jul 2013
The single most distressing symptom for more than 70% of patients with oesophageal cancer is difficulty in swallowing (dysphagia) caused by blockage of the gullet by a tumour. This causes severe restrictions on food intake, physical activity, social functioning and overall quality of life. Amongst the more effective treatments for improving swallowing, is the insertion of a metal stent across the blocked part, which then self-expands to open up the gullet (Self Expanding Metal Stent or SEMS). The addition of radiotherapy may help to improve the problems caused by dysphagia and provide an additional survival benefit. The purpose of this study is to test the impact of adding radiotherapy to SEMS on: - the length of time swallow remains improved for - quality of life - survival
Category Value
Study start date 2013-07-31

View full details